Leland Joins Genovac as Vice President of Production and Characterization

Pete Leland, a 20-year veteran of the biotechnology industry, has joined Genovac Antibody Discovery, Fargo, N.D., as its vice president of production and characterization.

Genovac is contract research organization that discovers, characterizes and produces antibodies for therapeutic, diagnostic and research markets. The company’s immunization technologies, combined with advanced hybridoma and the Berkeley Lights Beacon platform, enable success against the most challenging targets. Genovac operates a second scientific and production facility in Freiburg, Germany.

Leland leads the Genovac group that manufactures and tests antibodies, which its clients use to develop drugs that help fight genetic and infectious diseases like Covid-19, cancer and neurological disorders. He previously was a principal scientist for downstream process development at Catalent, Madison, Wis.

He holds a bachelor’s degree in chemistry from St. Olaf College, Northfield, Minn., and a doctorate in biochemistry from the University of Wisconsin-Madison.